Cutting edge: Sting mediates protection against colorectal tumorigenesis by governing the magnitude of intestinal inflammation

Journal of Immunology

Volumn 193, Issue 10, 2014, Pages 4779-4782

  Zhu, Qifan ^a,b   Man, Si Ming ^a   Gurung, Prajwal ^a   Liu, Zhiping ^a   Vogel, Peter ^a   Lamkanfi, Mohamed ^c,d   Kanneganti, Thirumala Devi ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Department of Molecular Biology   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MEMBRANE PROTEIN; PROTEIN STING; STAT3 PROTEIN; UNCLASSIFIED DRUG; CXCL1 CHEMOKINE; CXCL1 PROTEIN, MOUSE; MPYS PROTEIN, MOUSE; STAT3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CANCER SUSCEPTIBILITY; COLITIS; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; COLON; COLORECTAL NEOPLASMS; COMPLICATION; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY;

ANIMALS; CHEMOKINE CXCL1; COLITIS; COLON; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION; INTERLEUKIN-6; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NF-KAPPA B; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84910131670     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402051     Document Type: Article

References (29)

1. Siegel, R., D. Naishadham, and A. Jemal. 2013. Cancer statistics, 2013. CA Cancer J. Clin. 63: 11-30.
2. Chen, G. Y., and G. Núñez. 2011. Inflammasomes in intestinal inflammation and cancer. Gastroenterology 141: 1986-1999.
3. Elinav, E., R. Nowarski, C. A. Thaiss, B. Hu, C. Jin, and R. A. Flavell. 2013. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 13: 759-771.
4. Hornung, V., R. Hartmann, A. Ablasser, and K. P. Hopfner. 2014. OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids. Nat. Rev. Immunol. 14: 521-528.
5. Ishikawa, H., and G. N. Barber. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455: 674-678.
6. Ishikawa, H., Z. Ma, and G. N. Barber. 2009. STING regulates intracellular DNAmediated, type I interferon-dependent innate immunity. Nature 461: 788-792.
7. Burdette, D. L., K. M. Monroe, K. Sotelo-Troha, J. S. Iwig, B. Eckert, M. Hyodo, Y. Hayakawa, and R. E. Vance. 2011. STING is a direct innate immune sensor of cyclic di-GMP. Nature 478: 515-518.
8. Unterholzner, L., S. E. Keating, M. Baran, K. A. Horan, S. B. Jensen, S. Sharma, C. M. Sirois, T. Jin, E. Latz, T. S. Xiao, et al. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11: 997-1004.
9. Zhang, Z., B. Yuan, M. Bao, N. Lu, T. Kim, and Y. J. Liu. 2011. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12: 959-965.
10. Sun, L., J. Wu, F. Du, X. Chen, and Z. J. Chen. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339: 786-791.
11. Burdette, D. L., and R. E. Vance. 2013. STING and the innate immune response to nucleic acids in the cytosol. Nat. Immunol. 14: 19-26.
12. Kanneganti, T. D., N. Ozören, M. Body-Malapel, A. Amer, J. H. Park, L. Franchi, J. Whitfield, W. Barchet, M. Colonna, P. Vandenabeele, et al. 2006. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440: 233-236.
13. Sander, L. E., M. J. Davis, M. V. Boekschoten, D. Amsen, C. C. Dascher, B. Ryffel, J. A. Swanson, M. Müller, and J. M. Blander. 2011. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 474: 385-389.
14. Kailasan Vanaja, S., V. A. Rathinam, M. K. Atianand, P. Kalantari, B. Skehan, K. A. Fitzgerald, and J. M. Leong. 2014. Bacterial RNA:DNA hybrids are activators of the NLRP3 inflammasome. Proc. Natl. Acad. Sci. USA 111: 7765-7770.
15. Allen, I. C., E. M. TeKippe, R. M. Woodford, J. M. Uronis, E. K. Holl, A. B. Rogers, H. H. Herfarth, C. Jobin, and J. P. Ting. 2010. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitisassociated cancer. J. Exp. Med. 207: 1045-1056.
16. Zaki, M. H., P. Vogel, M. Body-Malapel, M. Lamkanfi, and T. D. Kanneganti. 2010. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J. Immunol. 185: 4912-4920.
17. Dihlmann, S., S. Tao, F. Echterdiek, E. Herpel, L. Jansen, J. Chang-Claude, H. Brenner, M. Hoffmeister, and M. Kloor. 2014. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients. Int. J. Cancer. 135: 2387-2396.
18. Hou, J., Y. Zhou, Y. Zheng, J. Fan, W. Zhou, I. O. Ng, H. Sun, L. Qin, S. Qiu, J. M. Lee, et al. 2014. Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma. Cancer Cell 25: 49-63.
19. Widau, R. C., A. D. Parekh, M. C. Ranck, D. W. Golden, K. A. Kumar, R. F. Sood, S. P. Pitroda, Z. Liao, X. Huang, T. E. Darga, et al. 2014. RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation. Proc. Natl. Acad. Sci. USA 111: E484-E491.
20. Puebla-Osorio, N., J. Kim, S. Ojeda, H. Zhang, O. Tavana, S. Li, Y. Wang, Q. Ma, K. S. Schluns, and C. Zhu. 2014. A novel Ku70 function in colorectal homeostasis separate from nonhomologous end joining. Oncogene 33: 2748-2757.
21. Sauer, J. D., K. Sotelo-Troha, J. von Moltke, K. M. Monroe, C. S. Rae, S. W. Brubaker, M. Hyodo, Y. Hayakawa, J. J. Woodward, D. A. Portnoy, and R. E. Vance. 2011. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79: 688-694.
22. Zaki, M. H., P. Vogel, R. K. Malireddi, M. Body-Malapel, P. K. Anand, J. Bertin, D. R. Green, M. Lamkanfi, and T. D. Kanneganti. 2011. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20: 649-660.
23. Hu, B., E. Elinav, S. Huber, C. J. Booth, T. Strowig, C. Jin, S. C. Eisenbarth, and R. A. Flavell. 2010. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc. Natl. Acad. Sci. USA 107: 21635-21640.
24. Bollrath, J., T. J. Phesse, V. A. von Burstin, T. Putoczki, M. Bennecke, T. Bateman, T. Nebelsiek, T. Lundgren-May, O. Canli, S. Schwitalla, et al. 2009. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15: 91-102.
25. Grivennikov, S., E. Karin, J. Terzic, D. Mucida, G. Y. Yu, S. Vallabhapurapu, J. Scheller, S. Rose-John, H. Cheroutre, L. Eckmann, and M. Karin. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitisassociated cancer. Cancer Cell 15: 103-113.
26. Yu, H., D. Pardoll, and R. Jove. 2009. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9: 798-809.
27. Chandra, D., W. Quispe-Tintaya, A. Jahangir, D. Asafu-Adjei, I. Ramos, H. O. Sintim, J. Zhou, Y. Hayakawa, D. K. Karaolis, and C. Gravekamp. 2014. STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer. Cancer Immunol. Res. 2: 901-910.
28. Westbrook, A. M., and R. H. Schiestl. 2010. Atm-deficient mice exhibit increased sensitivity to dextran sulfate sodium-induced colitis characterized by elevated DNA damage and persistent immune activation. Cancer Res. 70: 1875-1884.
29. Gehrke, N., C. Mertens, T. Zillinger, J. Wenzel, T. Bald, S. Zahn, T. Tüting, G. Hartmann, and W. Barchet. 2013. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 39: 482-495.